CLARUS THERAPEUTICS
Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.
CLARUS THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2003-01-01
Address:
Northbrook, Illinois, United States
Country:
United States
Website Url:
http://www.clarustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
847-562-4300
Email Addresses:
[email protected]
Total Funding:
122 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
H.I.G. Capital
H.I.G. Capital investment in Post-IPO Equity - Clarus Therapeutics
C-Bridge Capital
C-Bridge Capital investment in Venture Round - Clarus Therapeutics
Armentum Partners
Armentum Partners investment in Debt Financing - Clarus Therapeutics
H.I.G. Capital
H.I.G. Capital investment in Series C - Clarus Therapeutics
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series C - Clarus Therapeutics
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series B - Clarus Therapeutics
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series A - Clarus Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-18 | Clarus Therapeutics cutting staff, replacing CFO |
| 2022-01-18 | Clarus Therapeutics Appoints Dr. Zhanna Jumadilova as Chief Clinical Development Officer |
Official Site Inspections
http://www.clarustherapeutics.com
- Host name: 172.67.170.194
- IP address: 172.67.170.194
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
